TXN 6.87MELI -24.62LLY -12.91ZMT.TO -0.55WSP.TO 5.57XLY 0.03XLE 0.19XMI.TO -0.05
Johnson & Johnson (JNJ)

NYSE:JNJ

Johnson & Johnson (JNJ)

257.78
-1.58 (0.61%)
as of Oct 21, 2026, 8:00:00 pm Market Closed.
697 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
WEAK BUY

Johnson & Johnson(JNJ)

Jun 30, 2003
Book value is about $8 a share. Drug companies always seem to do well.
Photo of Benj GallanderBenj Gallander
No
Unlock Rating
$51.70

Stock price when the opinion was issued

$257.78

As of Oct 21, 2026. Market Open.

biotechnologypharmaceutical
BUY

Johnson & Johnson(JNJ)

May 16, 2003
Stable growth. Valuation may be a little high, but OK.
Photo of John ZechnerJohn ZechnerUnlock Rating
$56.04

Stock price when the opinion was issued

$257.78

As of Oct 21, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Johnson & Johnson(JNJ)

Jan 13, 2003
A defensive stock, so could lag a bit.
Photo of David BurrowsDavid BurrowsUnlock Rating
$56.04

Stock price when the opinion was issued

$257.78

As of Oct 21, 2026. Market Open.

biotechnologypharmaceutical
BUY

Johnson & Johnson(JNJ)

Dec 06, 2002
Great company. Into stents now which will be a big market opportunity.
Photo of Paul O'NeilPaul O'NeilUnlock Rating
$55.27

Stock price when the opinion was issued

$257.78

As of Oct 21, 2026. Market Open.

biotechnologypharmaceutical
BUY

Johnson & Johnson(JNJ)

Oct 23, 2002
Well rounded in different health areas.
Photo of Peter BriegerPeter BriegerUnlock Rating
$57.95

Stock price when the opinion was issued

$257.78

As of Oct 21, 2026. Market Open.

biotechnologypharmaceutical
BUY

Johnson & Johnson(JNJ)

Oct 15, 2002
Photo of Ray SteeleRay SteeleUnlock Rating
$59.56

Stock price when the opinion was issued

$257.78

As of Oct 21, 2026. Market Open.

biotechnologypharmaceutical
PAST TOP PICK

Johnson & Johnson(JNJ)

Sep 20, 2002
(Was a top pick on July 17. No change.) Still likes. A core holding.
Photo of Paul O'NeilPaul O'NeilUnlock Rating
$52.30

Stock price when the opinion was issued

$257.78

As of Oct 21, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Johnson & Johnson(JNJ)

Aug 16, 2002
Expensive now. Good long term hold.
Photo of Brad WillockBrad WillockUnlock Rating
$55.32

Stock price when the opinion was issued

$257.78

As of Oct 21, 2026. Market Open.

biotechnologypharmaceutical
TOP PICK

Johnson & Johnson(JNJ)

Jul 17, 2002
Great price. Should appreciate 15% a year. Good numbers.
Photo of Paul O'NeilPaul O'NeilUnlock Rating
$51.24

Stock price when the opinion was issued

$257.78

As of Oct 21, 2026. Market Open.

biotechnologypharmaceutical
BUY

Johnson & Johnson(JNJ)

Jul 10, 2002
A good long term hold. Good price.
Photo of Peter BriegerPeter BriegerUnlock Rating
$50.30

Stock price when the opinion was issued

$257.78

As of Oct 21, 2026. Market Open.

biotechnologypharmaceutical
WAIT

Johnson & Johnson(JNJ)

Jun 28, 2002
Benefiting from weaker US $. Wait for it to reverse its down trend.
Photo of David BurrowsDavid BurrowsUnlock Rating
$52.26

Stock price when the opinion was issued

$257.78

As of Oct 21, 2026. Market Open.

biotechnologypharmaceutical
BUY

Johnson & Johnson(JNJ)

May 30, 2002
Bullish. International.No generic drug problems. Good cash flow from a lot of coonsumer products.
Photo of Bill MacLachlanBill MacLachlanUnlock Rating
$61.37

Stock price when the opinion was issued

$257.78

As of Oct 21, 2026. Market Open.

biotechnologypharmaceutical
DON'T BUY

Johnson & Johnson(JNJ)

Apr 19, 2002
Great company, but expensive.
Photo of Brad WillockBrad WillockUnlock Rating
$64.49

Stock price when the opinion was issued

$257.78

As of Oct 21, 2026. Market Open.

biotechnologypharmaceutical
BUY

Johnson & Johnson(JNJ)

Feb 22, 2002
Prefers this and Pfizer over Merk.
Photo of Brad WillockBrad WillockUnlock Rating
$58.72

Stock price when the opinion was issued

$257.78

As of Oct 21, 2026. Market Open.

biotechnologypharmaceutical
BUY

Johnson & Johnson(JNJ)

Jan 22, 2002
Some good products. Grows well.
Photo of John ZechnerJohn ZechnerUnlock Rating
$59.12

Stock price when the opinion was issued

$257.78

As of Oct 21, 2026. Market Open.

biotechnologypharmaceutical
Showing 601 to 615 of 630 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

VZ -0.98$43.56
SNV 1.45$51.5
RKT -0.39$11.09
ELV -6.05$434.13
CSU.TO -3.94$3236.06

Today's Top Picks

TXN 6.87$284.65
MELI -24.62$1854.88
LLY -12.91$1270.75
ZMT.TO -0.55$112.15
WSP.TO 5.57$174.15

Popular Articles

Latest Sell Signals

LEN -0.11$76.98
ORCL -2.01$129.13
GEHC -1.22$69.01
PFE -0.26$29.85
BSX -0.905$44.675

Most Recent Experts

Gordon Reid

Gordon Reid

GoodReid Investment Counsel

Keith Richards

Keith Richards

ValueTrend Wealth Management

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Bruce Campbell (2)

Bruce Campbell (2)

Stone Castle Investment Management Inc.

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video

You may also like